Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q1 2024 Earnings Call Transcript May 13, 2024
Verrica Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.43738, expectations were $-0.54.
Operator: Ladies and gentlemen, good morning, and welcome to the Verrica Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a...
